We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRTV
3601
DELISTED
VERITIV CORPORATION
VRTV
| $610K | ﹤0.01% |
+10,163
| New | +$531K |
|
3602
PUT
International Paper
IP
$22.5B
| $607K | ﹤0.01% |
10,560
-57,130
| -84% | -$3.26M |
|
3603
SI-BONE Inc
SIBN
$799M
| $606K | ﹤0.01% |
19,265
-2,045
| -10% | -$66.1K |
|
3604
Washington Trust Bancorp
WASH
$755M
| $605K | ﹤0.01% |
11,779
+2,536
| +27% | +$134K |
|
3605
Kenon Holdings
KEN
$3.4B
| $603K | ﹤0.01% |
17,230
-4,195
| -20% | -$143K |
|
|
SLCA
3606
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $603K | ﹤0.01% |
+52,800
| New | +$612K |
|
|
ABTX
3607
DELISTED
Allegiance Bancshares
ABTX
| $603K | ﹤0.01% |
15,700
-2,780
| -15% | -$112K |
|
3608
Madrigal Pharmaceuticals
MDGL
$11.8B
| $601K | ﹤0.01% |
6,166
-2,856
| -32% | -$338K |
|
3609
PUT
Best Buy
BBY
$17.8B
| $598K | ﹤0.01% |
5,200
+1,300
| +33% | +$152K |
|
|
RUTH
3610
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $597K | ﹤0.01% |
25,891
+3,086
| +14% | +$75.4K |
|
3611
Real Brokerage
REAX
$375M
| $595K | ﹤0.01% |
+263,100
| New | +$616K |
|
3612
WisdomTree
WT
$3.44B
| $594K | ﹤0.01% |
95,719
-8,574
| -8% | -$56.5K |
|
3613
Central Pacific Financial
CPF
$1.03B
| $592K | ﹤0.01% |
22,796
-4,957
| -18% | -$136K |
|
3614
MBIA
MBI
$265M
| $592K | ﹤0.01% |
54,249
+7,860
| +17% | +$78.3K |
|
3615
ProShares UltraPro Dow 30
UDOW
$960M
| $592K | ﹤0.01% |
+16,198
| New | +$573K |
|
|
RUBY
3616
DELISTED
Rubius Therapeutics, Inc
RUBY
| $592K | ﹤0.01% |
24,230
+3,999
| +20% | +$100K |
|
3617
Legend Biotech
LEGN
$3.77B
| $590K | ﹤0.01% |
14,377
-2,116
| -13% | -$71.9K |
|
|
SWIR
3618
DELISTED
Sierra Wireless
SWIR
| $590K | ﹤0.01% |
31,073
-4,862
| -14% | -$75.7K |
|
3619
Gorman-Rupp
GRC
$2.3B
| $588K | ﹤0.01% |
17,191
+2,753
| +19% | +$95.8K |
|
3620
QCR Holdings
QCRH
$1.73B
| $588K | ﹤0.01% |
12,239
-1,254
| -9% | -$60K |
|
3621
iShares US Industrials ETF
IYJ
$2.04B
| $587K | ﹤0.01% |
+5,280
| New | +$583K |
|
|
DCUE
3622
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
| $587K | ﹤0.01% |
+6,000
| New | +$608K |
|
|
BFS
3623
Saul Centers
BFS
$824M
| $586K | ﹤0.01% |
12,786
+222
| +2% | +$9.63K |
|
|
MYOV
3624
DELISTED
Myovant Sciences Ltd.
MYOV
| $586K | ﹤0.01% |
26,055
-6,235
| -19% | -$131K |
|
|
GGPI
3625
DELISTED
Gores Guggenheim, Inc. Class A Common Stock
GGPI
| $586K | ﹤0.01% |
+60,000
| New | +$587K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.